KeyaMedical
  • Home
  • Products
    • DeepVessel FFR
    • CuraRad-ICH
  • Solutions
    • Diagnostic Solutions
    • Treatment Solutions
  • About Us
  • Resources
    • News
    • Publications
    • Glossary
  • Contact Us
    • DeepVessel FFR Demo
    • Solutions Inquiry
  • Careers
Select Page
Keya Medical Raises $46M in Series D Round

Keya Medical Raises $46M in Series D Round

by KeyaMedical | Jan 14, 2021 | All News, Investors, Press

Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.

Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital

Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital

by KeyaMedical | Nov 12, 2020 | All News, Investors, Press

Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.

Keya Medical Raises Over $20 Million in Series B+ Financing Round

Keya Medical Raises Over $20 Million in Series B+ Financing Round

by KeyaMedical | Aug 23, 2020 | Investors, Press

Keya Medical announced on Aug. 13 that it has raised over $20 million in Series B+ funding.

Keya Medical Receives Strategic Investment 

Keya Medical Receives Strategic Investment 

by KeyaMedical | Feb 19, 2020 | Investors, Press

Keya Medical announced today that it has received a strategic investment from Kunlun Wanwei Group, IDG Capital, Shanghai Guofang Parent Fund, and Yahui Capital.

DEEPVESSEL FFR is Approved for Clinical Use in China

DEEPVESSEL FFR is Approved for Clinical Use in China

by KeyaMedical | Jan 22, 2020 | Investors, Press

On January 15, 2020, the National Medical Products Administration in China issued the registration certificate approving DeepVessel FFR for clinical use.

Categories:

Recent Posts

  • DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
  • Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography
  • Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations
  • Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
  • The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes

Recent Comments

    Copyright Keya Medical © 2021